Skip to the main content
The Crier

Contract for the supply of human papillomavrius vaccine

Your saved contracts

What the buyer wrote

The provision of a vaccine to prevent highgrade cervical intraepithelial neoplasia (CIN grades 2 and 3) and cervical cancer causally related to Human Papillomavirus types 16 and 18, to be used in the national immunisation programme, and deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Sanofi Pasteur MSD Ltdends (30 Jun 2018)
Sanofi Pasteur MSD Ltdends (30 Jun 2018)

Details

What the buyer calls it
Contract for the supply of human papillomavrius vaccine
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Work starts
30 Jun 2016
Work ends
30 Jun 2018

Who the buyer named

The buyer published a contact address on this notice.

laura.boyle@dh.gsi.gov.uk